drugset / Trial / NCT00036075
Study Using CP-461 to Treat Advanced Prostate Cancer
Phase 2
Completed
25 enrolled
Astellas Pharma Inc
Cell Pathways · collabOSI Pharmaceuticals · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate whether an investigational drug, CP-461, is safe and effective for the treatment of patients with prostate cancer and who have measurable disease.
Timeline
- Start
- 2001-08
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CP-461 | Small molecule | — | — |